Mercado global de imagens de diapositivos inteiros – Tendências do setor e previsão para 2031

Análise e tamanho do mercado de imagens de diapositivos inteiros

No campo da patologia e do diagnóstico, a imagem de lâminas inteiras está a revolucionar a forma como as doenças, especialmente o cancro, são diagnosticadas. O WSI permite aos patologistas digitalizar lâminas de vidro inteiras, criando imagens de alta resolução que podem ser analisadas em ecrãs de computador. Esta abordagem digital aumenta a precisão e a eficiência do diagnóstico, permitindo técnicas avançadas de análise de imagens e a utilização de inteligência artificial . Além disso, o WSI facilita o diagnóstico remoto, permitindo aos patologistas aceder e avaliar lâminas a partir de qualquer parte do mundo, melhorando assim o acesso às opiniões dos especialistas e reduzindo os atrasos no diagnóstico.

O tamanho global do mercado global de imagens de diapositivos foi avaliado em 1,04 mil milhões de dólares em 2023 e deverá atingir 3,39 mil milhões de dólares até 2031, com um CAGR de 15,90% durante o período de previsão de 2024 a 2031 . Além dos insights sobre cenários de mercado, tais como como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research também incluem análise especializada aprofundada, epidemiologia de pacientes, análise de pipeline, análise de preços e enquadramento regulamentar.

Âmbito do relatório e segmentação de mercado       

Market Definition

Whole slide imaging (WSI) is a process that involves scanning traditional glass microscope slides to create high-resolution digital images of the entire tissue sample. These digital slides can be viewed, analyzed, and shared on computer screens, enabling remote diagnosis, digital archiving, and advanced image analysis. Whole slide imaging is widely used in pathology for educational, clinical, and research purposes.

Whole Slide Imaging Market Dynamics

Drivers

• Growing Supportive Government Policies

Government worldwide are increasingly recognizing the benefits of digital pathology and are implementing policies to promote its adoption. Initiatives include funding for healthcare technology upgrades, grants for research and development in digital pathology, and regulatory frameworks that encourage the use of digital tools in medical diagnostics. These policies aim to improve diagnostic accuracy, reduce healthcare costs, and enhance patient care. By providing financial incentives and regulatory support, governments are facilitating the widespread implementation of whole slide imaging technologies in medical institutions.

• Rising Prevalence of Chronic Diseases

Rising chronic diseases demands for accurate and efficient diagnostic tools that can handle large volumes of tissue samples with high precision. WSI addresses these needs by digitizing entire pathology slides, allowing pathologists to analyze samples more comprehensively and accurately. This technology facilitates earlier detection, precise diagnosis, and personalized treatment planning, crucial in managing chronic diseases effectively. Moreover, WSI supports research efforts aimed at understanding disease mechanisms and developing new therapies, further driving its adoption in healthcare systems worldwide.

Opportunities

• Advancements in Digital Pathology

Advancements in digital pathology include significant improvements in imaging technologies, such as higher resolution scanners and faster image processing capabilities, which enhance the quality and efficiency of slide digitization. Integration of artificial intelligence (AI) and machine learning algorithms further improves diagnostic accuracy by assisting pathologists in analyzing digital slides. Moreover, digital pathology enables seamless integration with electronic health records (EHRs) and laboratory information systems (LIS), streamlining workflow and enhancing data management. These technological advancements boost diagnostic capabilities and support remote consultations, telepathology, and collaborative research efforts, thereby driving the adoption of whole slide imaging across healthcare settings worldwide.

• Growth in Research and Development

Whole slide imaging enables researchers to efficiently analyze large volumes of tissue samples with high-resolution digital images, facilitating more detailed and accurate investigations into diseases and treatments. This capability is crucial in pharmaceutical and biotechnology sectors for drug discovery, efficacy testing, and toxicology studies. Additionally, whole slide imaging supports collaborative research efforts by allowing seamless sharing and remote access to digital slides among researchers globally, enhancing productivity and accelerating scientific discoveries.

Restraints/Challenges

• High Initial Investment

Whole slide imaging systems involve substantial costs for acquiring scanners, digital slide management software, and IT infrastructure capable of handling large image data. These upfront expenses can be prohibitive for smaller healthcare facilities, pathology labs, and research institutions, limiting their ability to adopt WSI technology. Moreover, ongoing maintenance and upgrade costs add to the financial burden.

• Growing Management Challenges

Management challenges include establishing robust storage solutions capable of managing massive image files securely and efficiently. Additionally, integrating WSI systems with existing laboratory information systems (LIS) and electronic health records (EHR) can be technically demanding and costly. Training pathologists and laboratory personnel to effectively use WSI technology and ensuring compliance with data privacy regulations further complicate implementation.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Whole Slide Imaging Market Scope

The market is segmented on the basis of technology, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

• Scanners
• IT Infrastructure
• Viewer
• Image Management System

Application

• Telepathology
• Cytopathology
• Immunohistochemistry
• Hematopathology

End User

• Hospitals
• Pharmaceutical and Biopharmaceutical Companies
• Laboratories
• Academic Institute
• Research
• Others

Whole Slide Imaging Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, technology, application and end user as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America.

Asia-Pacific dominates the market due to significant advancements in drug discovery research and growing awareness of the technology's benefits. Increased investment in healthcare infrastructure and the rising prevalence of chronic diseases also drive market growth. Additionally, government initiatives supporting digital pathology further bolster the adoption of whole slide imaging in the region.

North America is expected to experience substantial growth in the market due to increased government initiatives promoting the adoption of advanced technologies. This growth is further fueled by a rise in research and development activities across various industries. The region's emphasis on innovation and technological advancements is expected to drive significant market expansion during this period.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.

Base instalada de crescimento da infraestrutura de saúde e penetração de novas tecnologias

O mercado também fornece análises de mercado detalhadas para o crescimento de cada país em despesas de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado, impacto da tecnologia utilizando curvas de linha de vida e mudanças nos cenários regulamentares de saúde e o seu impacto no mercado. Os dados estão disponíveis para o período histórico 2016-2021.

Cenário competitivo e análise de mercado de imagens de diapositivos completos

O cenário competitivo do mercado fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas em relação ao mercado.

Alguns dos principais players que operam no mercado são:

• OLYMPUS CORPORATION (Japão)
• Leica Biosystems Nussloch GmbH (Alemanha)
• Hamamatsu Photonics KK (Japão)
• (Hungria)
• Koninklijke Philips NV (Holanda)
• Indica Labs, Inc.
• (EUA)
• Nikon Instruments Inc. (Japão)
• (EUA)
• Visiopharm A/S (Dinamarca)
• (EUA)
• (EUA)
• Siemens Healthineers AG (Alemanha)
• (EUA)
• Carl Zeiss AG (Alemanha)

SKU-63612